Ocular Therapeutix, Inc. · NASDAQ:OCUL
Deep Track Capital, LP reported a 9.53% stake in Ocular Therapeutix, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Deep Track Capital, LP reported a 9.53% stake in Ocular Therapeutix, Inc., 20,850,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.53%
- Shares
- 20,850,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deep Track Capital, LP | 9.53% | 20,850,000 |
| Deep Track Biotechnology Master Fund, Ltd. | 9.53% | 20,850,000 |
| David Kroin | 9.53% | 20,850,000 |
Source
Related
- Ocular Therapeutix, Inc.
- Deep Track Capital, LP
- Ocular Therapeutix, Inc. shareholders
- Schedule 13G/A · Deep Track Capital, LP · Feb 10, 2026
- Schedule 13G · Deep Track Capital, LP · Feb 10, 2026
- Schedule 13G/A · Deep Track Capital, LP · Nov 14, 2025
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2025
- Form 4 · Anderman Todd · Oct 13, 2026
- Form 4 · Heier Jeffrey S. · Oct 6, 2026
- Form 4 · Kaiser Peter · Oct 6, 2026
- Form 4 · Notman Donald · Sep 2, 2026
- Form 4 · Dugel Pravin · Aug 26, 2026